Department of Anatomy, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
J Immunother. 2010 Jun;33(5):510-22. doi: 10.1097/CJI.0b013e3181d75cef.
The requirement for CD4 T cells in priming and maintaining cytotoxic T-lymphocyte responses presents a long-standing paradox in cellular immunology. In this study, we used sequential coadministration of a DNA vaccine encoding an invariant (Ii) chain in which the class II-associated Ii-peptide region is replaced with CD4 T-helper epitope, PADRE [Pan human leukocyte antigen-DR reactive epitope (Ii-PADRE)] or Bcl-xL with a DNA vaccine encoding Sig/E7/LAMP-1 to verify the role of CD4 T cells for the generation of effectors and memory E7-specific CD8 T-cell immune responses. Sequential vaccination, with Ii-PADRE+Sig/E7/LAMP-1 priming followed by Bcl-xL+Sig/E7/LAMP-1 boosting led to generation of E7-specific CD8 T cells, and was nearly equivalent in effect to coadministration with Ii-PADRE+Sig/E7/LAMP-1 or Bcl-xL+Sig/E7/LAMP-1 at both prime and boost. The mice vaccinated with the Ii-PADRE+Sig/E7/LAMP-1 prime-Bcl-xL+Sig/E7/LAMP-1 boost regimen exhibited better long-term E7-specific immune responses and tumor prevention effects in vivo than the mice vaccinated with the reverse sequential coadministration. After CD4 T-cell depletion, mice primed with Ii-PADRE+Sig/E7/LAMP-1 generated low numbers of E7-specific CD8 T cells and suppressed long-term memory CD8 T-cell response regardless of the sequence or combination of DNA vaccines administered. Mice primed with Bcl-xL+Sig/E7/LAMP-1 only suppressed long-term memory CD8 T-cell response after depletion of CD4 T cells before priming. Our findings suggest that activated CD4 T cells at prime phase are important to generate the antigen-specific CD8 T-cell immune responses and CD4 T cells, which are naive or activated, play a role to maintain the long-term memory responses.
CD4 T 细胞在启动和维持细胞毒性 T 淋巴细胞反应中的需求在细胞免疫学中提出了一个长期存在的悖论。在这项研究中,我们使用顺序共施用编码不变(Ii)链的 DNA 疫苗,其中 II 类相关的 Ii-肽区被 CD4 T 辅助表位、PADRE [泛人白细胞抗原-DR 反应性表位(Ii-PADRE)]或 Bcl-xL 取代,用编码 Sig/E7/LAMP-1 的 DNA 疫苗共免疫,以验证 CD4 T 细胞在产生效应物和记忆 E7 特异性 CD8 T 细胞免疫反应中的作用。Ii-PADRE+Sig/E7/LAMP-1 初免后用 Bcl-xL+Sig/E7/LAMP-1 加强免疫的序贯接种导致 E7 特异性 CD8 T 细胞的产生,其效果几乎等同于 Ii-PADRE+Sig/E7/LAMP-1 或 Bcl-xL+Sig/E7/LAMP-1 的共免疫。用 Ii-PADRE+Sig/E7/LAMP-1 初免-Bcl-xL+Sig/E7/LAMP-1 加强免疫方案接种的小鼠在体内表现出比用相反顺序共免疫的小鼠更好的长期 E7 特异性免疫反应和肿瘤预防效果。在耗尽 CD4 T 细胞后,用 Ii-PADRE+Sig/E7/LAMP-1 初免的小鼠产生的 E7 特异性 CD8 T 细胞数量较少,并抑制长期记忆 CD8 T 细胞反应,而与给予的 DNA 疫苗的顺序或组合无关。用 Bcl-xL+Sig/E7/LAMP-1 初免的小鼠仅在初免前耗尽 CD4 T 细胞后抑制长期记忆 CD8 T 细胞反应。我们的研究结果表明,在启动阶段激活的 CD4 T 细胞对于产生抗原特异性 CD8 T 细胞免疫反应很重要,而幼稚或激活的 CD4 T 细胞对于维持长期记忆反应发挥作用。